Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.
about
P2860
Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Randomised, double-blind, plac ...... e to severe persistent asthma.
@ast
Randomised, double-blind, plac ...... e to severe persistent asthma.
@en
type
label
Randomised, double-blind, plac ...... e to severe persistent asthma.
@ast
Randomised, double-blind, plac ...... e to severe persistent asthma.
@en
prefLabel
Randomised, double-blind, plac ...... e to severe persistent asthma.
@ast
Randomised, double-blind, plac ...... e to severe persistent asthma.
@en
P2093
P2860
P1433
P1476
Randomised, double-blind, plac ...... e to severe persistent asthma.
@en
P2093
Craig LaForce
Kai-Michael Beeh
Martina Gahlemann
Matjaž Fležar
Robert Toorawa
P2860
P2888
P356
10.1186/S12931-015-0243-1
P577
2015-07-16T00:00:00Z
P5875
P6179
1023716249